東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Clinical Trials." ]

切換: 標籤 | MARC模式 | ISBD

Anticancer drug development guide : ...

Andrews, Paul A.

FindBook

Google Book

Amazon

博客來

Anticancer drug development guide : = preclinical screening, clinical trials, and approval /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Anticancer drug development guide :/ edited by Beverly A. Teicher, Paul A. Andrews.
其他題名:	preclinical screening, clinical trials, and approval /
其他作者:	Andrews, Paul A.
出版者:	Totowa, N.J. :Humana Press, : c2004.,
面頁冊數:	xiv, 450 p. :ill. ;26 cm. +1 CD-ROM (4 3/4 in.).
叢書名:	Cancer drug discovery and development.
內容註:	High-volume screening / Michel Pag?-- High-throughput screening in industry / Michael D. Boisclair ... [et al.] -- The NCI human tumor cell line (60-cell) screen: concept, implementation, and applications / Michael R. Boyd -- Human tumor screening/ Axel-R. Hanauske, Susan G. Hilsenbeck, and Daniel D. Von Hoff -- Murine L1210 and P388 leukemias / William R. Waud -- In vivo methods for screening and preclinical testing: use of rodent solid tumors for drug discovery/ Thomas Corbett ... [et al.] -- Human tumor xenograft models in NCI drug development / Michael C. Alley ... [et al.] -- Specialized in vitro/in vivo procedures employed by the NCI in preclinical drug evaluations / Melinda G. Hollingshead ... [et al.] --.
內容註:	Patient-like orthotopic metastatic models of human cancer / Robert M. Hoffman -- Preclinical models for combination therapy / Beverly A. Teicher -- Models for biomarkers and minimal residual tumor/ Beverly A. Teicher -- Spontaneously occurring tumors in companion animals as models for drug development / David M. Vail and Douglas H. Thamm -- Nonclinical testing: from theory to practice/ Denis Roy and Paul A. Andrews -- Nonclinical testing for oncology drug products / Paul A. Andrews and Denis Roy -- Nonclinical testing for oncology biologic products / Carolyn M. Lauren髺t, Denis Roy, and Paul A. Andrews --.
內容註:	Working with the national cancer institute / Paul Thambi and Edward A. Sausville -- Phase I trial design and methodology for anticancer drugs/ Patrick V. Acevedo, Deborah L. Toppmeyer, and Eric H. Rubin -- Phase II trials: conventional design and novel strategies in the era of targeted therapies / Keith T. Flaherty and Peter J. O'Dwyer --.
內容註:	Drug development in Europe: the academic perspective / Chris Twelves ... [et al.] -- The phase III clinical cancer trial/ Ramzi N. Dagher and Richard Pazdur -- Assessing tumor-related symptoms and health-related quality of life in cancer clinical trials: a regulatory perspective/ Judy H. Chiao, Grant Williams, and Donna Griebel -- The role of the oncology drug advisory committee in the FDA review process for oncologic products / Leslie A. Vaccari -- FDA role in cancer drug development and requirements for approval/ Susan Flamm Honig.
標題:	Antineoplastic agents - Development. -
電子資源:	http://www.loc.gov/catdir/toc/ecip0411/2003024925.htmlhttp://www.loc.gov/catdir/toc/ecip0411/2003024925.html
ISBN:	1588292282 :

Anticancer drug development guide : = preclinical screening, clinical trials, and approval /
Anticancer drug development guide :preclinical screening, clinical trials, and approval /edited by Beverly A. Teicher, Paul A. Andrews. - 2nd ed. - Totowa, N.J. :Humana Press,c2004. - xiv, 450 p. :ill. ;26 cm. +1 CD-ROM (4 3/4 in.). - Cancer drug discovery and development..

Includes bibliographical references and index.

High-volume screening / Michel Pag?-- High-throughput screening in industry / Michael D. Boisclair ... [et al.] -- The NCI human tumor cell line (60-cell) screen: concept, implementation, and applications / Michael R. Boyd -- Human tumor screening/ Axel-R. Hanauske, Susan G. Hilsenbeck, and Daniel D. Von Hoff -- Murine L1210 and P388 leukemias / William R. Waud -- In vivo methods for screening and preclinical testing: use of rodent solid tumors for drug discovery/ Thomas Corbett ... [et al.] -- Human tumor xenograft models in NCI drug development / Michael C. Alley ... [et al.] -- Specialized in vitro/in vivo procedures employed by the NCI in preclinical drug evaluations / Melinda G. Hollingshead ... [et al.] --.

Minimum system requirements: Adobe reader 6.0 or later.

ISBN: 1588292282 :US149.50

LCCN: 2003024925Subjects--Topical Terms:

752563
Antineoplastic agents
--Development.

LC Class. No.: RC271.C5 / A6722 2004

Dewey Class. No.: 616.99/4061

National Library of Medicine Call No.: QV 269 / A62953 2004

Anticancer drug development guide : = preclinical screening, clinical trials, and approval /
LDR:03281pam a2200289 a 45 001 699514
005 20060308
008 060112s2004 njua b 001 0 eng
010 $a 2003024925
020 $a 1588292282 : $c US149.50
020 $a 1592597394 (e-book)
035 $a CS94T0057
040 $a DNLM/DLC $c DLC $d DLC
050 0 0 $a RC271.C5 $b A6722 2004
060 1 0 $a QV 269 $b A62953 2004
082 0 0 $a 616.99/4061 $2 22
245 0 0 $a Anticancer drug development guide : $b preclinical screening, clinical trials, and approval / $c edited by Beverly A. Teicher, Paul A. Andrews.
250 $a 2nd ed.
260 $a Totowa, N.J. : $c c2004. $b Humana Press,
300 $a xiv, 450 p. : $b ill. ; $c 26 cm. + $e 1 CD-ROM (4 3/4 in.).
440 0 $a Cancer drug discovery and development.
504 $a Includes bibliographical references and index.
505 0 $a High-volume screening / Michel Pag?-- High-throughput screening in industry / Michael D. Boisclair ... [et al.] -- The NCI human tumor cell line (60-cell) screen: concept, implementation, and applications / Michael R. Boyd -- Human tumor screening/ Axel-R. Hanauske, Susan G. Hilsenbeck, and Daniel D. Von Hoff -- Murine L1210 and P388 leukemias / William R. Waud -- In vivo methods for screening and preclinical testing: use of rodent solid tumors for drug discovery/ Thomas Corbett ... [et al.] -- Human tumor xenograft models in NCI drug development / Michael C. Alley ... [et al.] -- Specialized in vitro/in vivo procedures employed by the NCI in preclinical drug evaluations / Melinda G. Hollingshead ... [et al.] --.
505 0 $a Patient-like orthotopic metastatic models of human cancer / Robert M. Hoffman -- Preclinical models for combination therapy / Beverly A. Teicher -- Models for biomarkers and minimal residual tumor/ Beverly A. Teicher -- Spontaneously occurring tumors in companion animals as models for drug development / David M. Vail and Douglas H. Thamm -- Nonclinical testing: from theory to practice/ Denis Roy and Paul A. Andrews -- Nonclinical testing for oncology drug products / Paul A. Andrews and Denis Roy -- Nonclinical testing for oncology biologic products / Carolyn M. Lauren髺t, Denis Roy, and Paul A. Andrews --.
505 0 $a Working with the national cancer institute / Paul Thambi and Edward A. Sausville -- Phase I trial design and methodology for anticancer drugs/ Patrick V. Acevedo, Deborah L. Toppmeyer, and Eric H. Rubin -- Phase II trials: conventional design and novel strategies in the era of targeted therapies / Keith T. Flaherty and Peter J. O'Dwyer --.
505 0 $a Drug development in Europe: the academic perspective / Chris Twelves ... [et al.] -- The phase III clinical cancer trial/ Ramzi N. Dagher and Richard Pazdur -- Assessing tumor-related symptoms and health-related quality of life in cancer clinical trials: a regulatory perspective/ Judy H. Chiao, Grant Williams, and Donna Griebel -- The role of the oncology drug advisory committee in the FDA review process for oncologic products / Leslie A. Vaccari -- FDA role in cancer drug development and requirements for approval/ Susan Flamm Honig.
538 $a Minimum system requirements: Adobe reader 6.0 or later.
650 $a Antineoplastic agents $x Development. $3 752563
650 $a Antineoplastic Agents $x standards. $3 752564
650 $a Clinical Trials. $3 752565
650 $a Drug Approval. $3 752566
650 $a Drug Design. $3 550958
650 $a Drug Evaluation, Preclinical. $3 752567
700 $a Andrews, Paul A. $3 752561
700 $a Teicher, Beverly A., $d 1952-. $3 752562
856 4 1 $3 Table of contents $u http://www.loc.gov/catdir/toc/ecip0411/2003024925.html $z http://www.loc.gov/catdir/toc/ecip0411/2003024925.html